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Angiosarcomas are localized or multicentric tu-
mors with various grades of differentiation that origi-
nate in the endothelium of the blood and lymphatic 
vessels. Angiosarcoma is an extremely aggressive ma-
lignant neoplasm with a 6-month median survival. 
Primary occurrence in the kidney is rare, with 24 cases 
described to date. We present a case of primary renal 
angiosarcoma in a 65-year-old male patient. It was an 
incidental CT scan finding that showed 3 tumors in 
the left kidney. Nephrectomy with ureterectomy was 
performed. Macroscopic examination revealed 3 nod-
ular hemorrhagic yellowish tumors located subcapsu-
larly in the central area of the left kidney, measuring 
0.5 to 4.5 cm in diameter. Microscopically, it was a 
malignant neoplasm composed of large sheets, cords 
and small anastomosing vascular spaces, covered by 
pleomorphic epithelioid and spindle-shaped cells with 
voluminous and hyperchromatic irregular nuclei. Mi-
totic figures were frequent. Immunohistochemically, 
neoplastic cells showed strong positivity for C31, C34 
and factor VIII. In conclusion, primary renal an-
giosarcomas are extremely rare aggressive tumors of 
endothelial cells. About 24 cases of this tumor have 
been documented. The mean patient age is 58 years. 
The etiology is unknown. They usually occur near 
renal capsule. Clinical symptoms are flank pain and 
hematuria. Differential diagnosis includes retroperi-
toneal hematoma and hemorrhagic renal tumors. The 
prognosis of renal angiosarcoma is poor, with rapid 
development of hematogenous metastasis.
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It is well known that dogs are affected with a natu-
ral homolog of human atopic dermatitis. The aim is to 
describe canine atopic dermatitis (CAD) and its points 
of clinical interests for veterinary and human derma-
tologists. Relevant articles were identified from three 
databases: MEDLINE (since 1966), ISI (Thomson) 
Science Citation Index Expanded (since 1945) and 
CAB Abstracts (since 1975). CAD is a genetically 
predisposed inflammatory and pruritic allergic skin 
disease with characteristic clinical features associated 
with IgE antibodies most commonly directed against 
environmental allergens. It is the most common al-
lergic skin disease of the dog. Pruritus is the essential 
clinical feature, along with normal appearing skin or 
skin with erythema, small erythematous papular der-
matitis, or erythematous macules. In dogs, pruritus 
is considered a hallmark of atopic dermatitis and is 
emphasized by feet licking and nose or head rubbing. 
Recently, new diagnostic criteria for CAD have been 
proposed by Favrot et al., including a set of 8 clinical 
features. Methods such as intradermal testing (ASIT) 
and allergen-specific IgE serology serve as orienta-
tion for clinicians in the diagnostic and therapeutic 
approach. Treatment of acute flares of CAD includes 
identification and removal of the allergenic causes of 
flares, antimicrobial therapy, improvement of skin and 
coat hygiene, and care and reduction of pruritus and 
skin lesions with pharmacological agents. Human 
atopic dermatitis is a common, multifactorial, chronic 
and often relapsing inflammatory skin disease. In the 
etiopathogenesis of human atopic dermatitis, there are 
well known interactions among genetic, environmen-
tal, skin barrier, immune factors, and stress. Current 
treatment of severe atopic dermatitis consists almost 
exclusively of topical and systemic corticosteroids. 
Disease management involves skin hydration through 
daily baths and intensive emollient therapy, avoidance 
of allergens, and in some cases use of anti-histamines 
to alleviate pruritus.
